The management of severe hypercalcaemia.
作者信息
Altmann P, Cunningham J
机构信息
Department of Nephrology, The London Hospital, UK.
出版信息
Postgrad Med J. 1987 Feb;63(736):77-9. doi: 10.1136/pgmj.63.736.77.
Abstract
摘要
相似文献
1
The management of severe hypercalcaemia.重度高钙血症的管理
Postgrad Med J. 1987 Feb;63(736):77-9. doi: 10.1136/pgmj.63.736.77.
2
The management of malignant hypercalcaemia.恶性高钙血症的管理
Drugs. 1996 Dec;52(6):837-48. doi: 10.2165/00003495-199652060-00005.
3
Treatment of hypercalcemia associated with malignancy.与恶性肿瘤相关的高钙血症的治疗。
Semin Oncol. 1978 Jun;5(2):141-53.
4
Management of hypercalcemia after renal transplantation.肾移植后高钙血症的处理。
Nefrologia. 2013 Nov 13;33(6):751-7. doi: 10.3265/Nefrologia.pre2013.Aug.11888.
5
Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia.
Nephrol Dial Transplant. 2005 Dec;20(12):2865. doi: 10.1093/ndt/gfi110. Epub 2005 Aug 22.
6
Medical management of hypercalcemia.高钙血症的医学管理。
Calcif Tissue Int. 2004 Jan;74(1):1-11. doi: 10.1007/s00223-001-1135-6. Epub 2003 Oct 6.
7
[Treatment of hypercalcemia using furosemide].[使用呋塞米治疗高钙血症]
Union Med Can. 1975 Feb;104(2):272-5.
8
Immobilisation hypercalcaemia in adults and treatment with clodronate.成人制动后高钙血症及氯膦酸盐治疗
Br Med J (Clin Res Ed). 1984 Oct 27;289(6452):1111-2. doi: 10.1136/bmj.289.6452.1111.
9
Mechanism of malignant hypercalcaemia in carcinoma of the breast.乳腺癌恶性高钙血症的机制
Br Med J (Clin Res Ed). 1985 Sep 21;291(6498):776-9. doi: 10.1136/bmj.291.6498.776.
10
Bisphosphonate or RANK-L inhibitor for tumour-induced hypercalcaemia?双膦酸盐或RANK-L抑制剂用于治疗肿瘤引起的高钙血症？
Neth J Med. 2012 Jun;70(5):250-1.
引用本文的文献
1
Management of hyperparathyroid patients with grave hypercalcemia.
World J Surg. 1991 Nov-Dec;15(6):730-7. doi: 10.1007/BF01665307.
本文引用的文献
1
Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.二氯亚甲基二膦酸盐对骨Paget病以及原发性甲状旁腺功能亢进或恶性疾病所致高钙血症的作用。
Lancet. 1980 May 17;1(8177):1043-7. doi: 10.1016/s0140-6736(80)91496-8.
2
Intravenous etidronate in the management of malignant hypercalcemia.静脉注射依替膦酸二钠治疗恶性高钙血症
Arch Intern Med. 1985 Mar;145(3):449-52.
3
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.前列腺素作为与某些类型癌症相关的高钙血症的介质。
N Engl J Med. 1975 Dec 18;293(25):1278-83. doi: 10.1056/NEJM197512182932502.
4
Pathogenesis of hypercalcemia in lymphosarcoma cell leukemia. Role of an osteoclast activating factor-like substance and a mechanism of action for glucocorticoid therapy.
Am J Med. 1978 Oct;65(4):600-6. doi: 10.1016/0002-9343(78)90847-1.
5
Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
Lancet. 1979 Apr 14;1(8120):803-5. doi: 10.1016/s0140-6736(79)91319-9.
Zotero 插件